Introduction
The carnitine/acylcarnitine carrier (CAC) belongs to the mitochondrial carrier protein family; it plays a central role in the β-oxidation of fatty acids [1] . The amino acid sequence of the CAC shows all the specific properties of the carrier family, as the tripartite structure and the threefold repeated signature motif PX [DE] XX[RK] [2] . It shows also the typical hydropathy profile of the mitochondrial carriers, which is characterized by six hydrophobic transmembrane segments (H1-H6) connected by five hydrophilic loops, two of which are exposed towards the cytosolic side (h 23 , h 45 ) and three towards the matrix side (h 12 , h 34 , h 56 ) of the protein; the three matrix loops are much larger than the cytosolic ones. The CAC is encoded in Homo sapiens by the gene SLC25A20 [3] that maps to chromosome 3p21.31, in Saccharomyces cerevisiae by the gene CRC [4] and in Aspergillus nidulans by the gene acuH [5] . The CAC proteins are grouped in a sub-family characterized by the RXXPANAAXF motif which is located in the H6 [5] . The CAC from rat liver has been widely characterized on the functional point of view after the purification and reconstitution in liposomes [6 and see 7 for Refs.]. This carrier catalyses efficient carnitine/acylcarnitine and carnitine/carnitine antiports and, in the absence of counter-substrate, a 10-times slower carnitine uniport. The transport protein inserts itself into the liposomal membrane rightside out compared to mitochondria; thus, the extraliposomal and intraliposomal sides correspond to the cytosolic and matrix sides, respectively. The substrate antiport catalysed by the CAC occurs via a ping-pong transport mechanism, implying that one substrate-binding site is alternatively exposed to the cytosol (c-state) or the matrix (m-state) [8] . Sulfhydryl reagents strongly inhibit the transport function of CAC [9] . To investigate the structure/function relationships by sitedirected mutagenesis, the transport protein has been over-expressed in Escherichia coli and reconstituted in liposomes in active state. The recombinant CAC resembles all the main functional and kinetic properties of the native protein [10] . Using reconstituted wild-type and mutant over-expressed proteins, it was revealed that Cys-136 is responsible for the inhibition of the CAC by the SH reagents. This residue is accessible from the external (cytosolic) side of the proteoliposomes to hydrophilic SH reagents [11] . Further site-directed mutagenesis studies showed that Cys-136, which is located in H3, and Cys-155, which is located in h 34 , can come in contact during some steps of the catalytic cycle [7] . The homology structural model of the CAC [7] obtained on the basis of the tertiary structure of the ADP/ATP carrier [12] , is in agreement with the experimental findings. Very recently it was found that the accessibility of Cys-136 and Cys-155 from the external (cytosolic) side of the reconstituted CAC in the proteoliposomes depends on the conformational state of the protein. The Cys residues are located in a mobile structure of the protein that become more accessible to the external (cytosolic) aqueous environment when the transporter is in m-state [13] . Further information on the structure/ function relationships could be obtained by mutagenesis of His residues, which are often involved in the function of membrane transporters [14] [15] [16] [17] [18] [19] [20] . The rat CAC has two His residues, one of which is conserved in all the members of the CAC subfamily. In the present paper the relationships between the function of the carrier and the two His residues have been investigated by site-directed mutagenesis. These studies, in agreement with multialignment and homology structure predictions, revealed that the conserved His-29 is involved in the transport pathway, whereas the non-conserved His-205 does not play any major role in the CAC.
Experimental procedures

Materials
Sephadexes G-50, G-75 and G-200 were purchased from Pharmacia, L-[methyl-3 H]carnitine from Amersham, egg-yolk phospholipids (L-α-phosphatidylcholine from fresh turkey egg yolk), Pipes, Triton X-100, cardiolipin, L-carnitine, L-acetylcarnitine, DL-(n)acylcarnitines and N-dodecanoylsarcosine (sarkosyl) from Sigma. All other reagents were of analytical grade.
Site-directed mutagenesis, overexpression and isolation of the CAC proteins
The previously constructed pMW7-WTratCAC recombinant plasmid was used to introduce the mutations in the CAC protein [11] . The amino acid replacements were performed with complementary mutagenic primers using the overlap extension method [21] and the High Fidelity PCR System (Roche). The PCR products were purified by the Gene Clean Kit (La Jolla), digested with NdeI and HindIII Fig. 1 . Alignment of proteins of the mitochondrial carnitine carrier subfamily. Proteins identified (R. norvegicus NP446417 [10] , H. sapiens NP000378 [26] , A. thaliana NP568670 [47] , S. cerevisiae NP014743 [4] , A. nidulans AJ011563 [5] (restriction sites added at the 5′ end of forward and reverse primers, respectively) and ligated into the pMW7 expression vector. All mutations were verified by DNA sequencing, and, except for the desired base changes, all of the sequences were identical to that of rat CAC cDNA. The resulting plasmids were transformed into E. coli C0214. Bacterial overexpression, isolation of the inclusion body fraction, solubilization and purification of the wild-type CAC and mutant CAC proteins were performed as described previously [11] .
Reconstitution of wild-type and mutant CAC proteins in liposomes
The recombinant proteins were reconstituted into liposomes as described previously [11] . The concentration of intraliposomal carnitine was 13 mM. The external substrate was removed from proteoliposomes on Sephadex G-75 columns.
Transport measurements
Transport at 25°C was started by adding 0.1 mM [
3 H]carnitine to proteoliposomes and terminated by the addition of 1.5 mM NEM [6] . In controls, the inhibitor was added together with the labelled substrate, according to the inhibitor stop method [22] . This strategy allows to subtract, from the experimental samples, the aliquot of radiolabelled carnitine diffusing through the liposomal membrane. Finally, the external substrate was removed by chromatography on Sephadex G-50 columns, and the radioactivity in the liposomes was measured [22] . The experimental values were corrected by subtracting control values. All of the transport activities were determined by taking into account the efficiency of reconstitution (i.e. the share of successfully incorporated protein). Laemmli [23] as previously described [11] . The amount of recombinant protein was estimated on Coomassie blue-stained SDS-PAGE gels by the Bio-Rad GS-700 Imaging Densitometer equipped with the software Bio-Rad MultiAnalist, using bovine serum albumin as standard. The extent of incorporation of the recombinant protein into liposomes was determined as described in Phelps et al. [14] , with the modifications reported in ref. [11] . N-terminal sequencing was carried out as described before [24] . The homology model of the rat CAC was built based upon the structure of the bovine ADP/ATP carrier [12] by using the computer application Swiss PDB Viewer [25] .
Other methods
SDS-PAGE was performed according to
Results
Functional analysis of the mutant CAC proteins
It was previously reported that some members of the mitochondrial carrier family share the RXXPANAAXF sequence motif, which is located in the sixth hydrophobic segment H6 [5] . It was proposed that the proteins containing this motif constitute the CAC subfamily [5, 26] . Indeed, the RXXPANAAXF motif is conserved in the CAC of R. norvegicus, H. sapiens, A. nidulans, C. elegans, D. melanogaster, as previously described [5] and also in the CACs of M. musculus, B. taurus, D. rerio, S. cerevisiae, A. thaliana and O. sativa as depicted in Fig. 1 . The multialignment highlights that one of the two His of the rat CAC, His-29, is conserved in all the CACs. This residue is positioned before the first of the three repeated PX[DE]XX[RK] motifs. As the RXXPANAAXF motif, this His residue is found in the CAC subfamily and in few other members of the mitochondrial carrier family (see Discussion section). Differently, the second His of the rat CAC, His-205, is not conserved within the CAC subfamily. In the homology model of CAC [7] , which was built using the structure of the ADP/ATP carrier in c-state as template [12] , His-29 is located in the central water filled cavity, slightly above the charged network that closes the cavity at the bottom. His-205 is localized at the beginning of the α-helix H5 after the short loop h 45 which connects H4 and H5 and faces towards the external aqueous environment (ref. [7] and see Fig. 6 ).
Both residues have been substituted with the small hydrophobic Ala or with the charged Lys and Asp. The functional consequence of the mutations have been analysed in proteoliposomes reconstituted with the different mutant proteins over-expressed in E. coli. The incorporation of the proteins into the liposomal membrane was tested as previously described [11, 14] and no significant difference of incorporation was found for the various mutants (not shown). In Fig. 2 A the ]carnitine mediated by H29N was about 10% of the wild-type, whereas the uptake mediated by H29Q was more than 80% of the wild-type. These data indicated that the H-bonding property of His-29 is the most important for the function and is very critical since only Gln, not Asn, restored the activity of the transporter. It cannot be excluded that His-29 may also form hydrophobic interaction, which may explain the residual activity of the mutants in which His-29 had been replaced with hydrophobic or aromatic residues. However, the residual activity may be more likely due to the ability of these residues to form weaker H-bonds in proteins [30] .
The effect of the substitution of His-29 and His-205 on the kinetics of the CAC was further investigated ( Table 1 ). The substitution of His-205 did not lead to significant variations of the Km and Vmax. Whereas, the substitution of His-29 led to an increase of the Km for carnitine which, in the H29N mutant, reached a value more than three fold that of the wild-type. The Vmax values of the His-29 mutants were lower than that of the wild-type with the exception of H29Q which showed the same value of the wild-type. The inactive mutants H29K, H29D and H29R could not be tested for kinetic properties since their transport activity was too low even in the presence of very high (60 mM) intraliposomal substrate concentrations, a condition previously used to study mutants of the mitochondrial citrate transporter (CTP) with low activity [31] .
Substrate protection against the inhibition by DEPC
Since the CAC functions according to rapid-equilibrium mechanism [8] , the Km increase of the His-29 mutants highlighted a decrease of affinity towards carnitine; this might indicate the occurrence of a direct interaction of His-29 with the substrate. This hypothesis was further investigated by inhibition studies. The sensitivity of the CAC to DEPC, an His-specific reagent [32] , was tested. 2 mM DEPC inhibited 90% of the transport activity of the wildtype. However, besides H29A (62% inhibition) and H205A (82% inhibition) also the H29A/H205D mutant (i.e., no His in the recombinant protein) was inhibited (56%), indicating that DEPC also reacted with residues different from His, as it was previously found for other proteins [32] . To prevent the unspecific reaction, proteoliposomes were pre-treated with PLP and mersalyl to protect the Lys and Cys residues which could react with DEPC [32] . After the following incubation with DEPC, the proteoliposomes were treated with DTE to remove the mersalyl and subsequently passed through Sephadex G-75 columns to remove the PLP [33] and the unreacted DEPC; the residual activity was then measured. As expected (Fig. 3) , a lower extent of inhibition was generally found after these treatments. The absence of inhibition of the mutant H29A/H205D demonstrated that DEPC had reacted specifically with His residues. The activities of wild-type and H205A proteins were inhibited about 30% and 25%, respectively. The activity of the H29A mutant was inhibited less than 15%, i.e., H29A showed a strong decrease of the sensitivity to DEPC compared to the wild-type and H205A proteins, indicating that most of the inhibitory effect was due to His-29. The presence of 20 mM carnitine during the incubation with DEPC mostly prevented the inhibition of the wildtype and of the H205A mutant (containing His-29), whereas had not significant effect on the mutant H29A. The addition of 0.5 mM carnitine (close to the Km value) instead of 20 mM, during the incubation with DEPC of the H205A mutant, resulted in inhibition of 13.5 ± 4.1% (three experiments; not shown), i.e., the protection was about half of the maximal effect. These findings indicated a possible interaction of His-29 with the substrate.
Selectivity of CAC mutants towards acylcarnitines
It is known that CAC accepts carnitine acyl derivatives as physiological substrates, with higher affinities towards acylcarnitines with a longer carbon chain. These compounds behave as competitive inhibitors towards carnitine since they bind to the same site [10, 34] . The effect of the substitution of His-29 on the sensitivity towards acylcarnitines has been tested measuring the inhibition of the [ 3 H] carnitine transport in proteoliposomes reconstituted with H29A, H29N, H29Q, H29Y, H29F and H205A, in comparison with the wildtype. For a reliable estimation of the variations of sensitivity, the concentration of each inhibitor was chosen (see legend to the Fig. 4 ) to obtain, in the wild-type, residual activities of roughly 50%. As shown in Fig. 4A , the mutant H29A showed a slight reduction of sensitivity towards acetylcarnitine (n = 2) with respect to the wild-type; whereas it showed a more evident reduction of sensitivity towards longer acylcarnitines. Some reduction of sensitivity towards acylcarnitines was also found for H29F and H29Y, but shifted towards longer acyl chains. In the case of H29N a strong decrease of sensitivity towards all the acyl derivatives was found. Differently, H29Q exhibited sensitivity towards acylcarnitines similar to that of the wild-type, except for the C2 derivative. H205A showed sensitivity to the acylcarnitines overlapping that of the wild-type.
pH dependence of H29A and H205A mutants
The pH dependence of the H29A and H205A mutants was studied in comparison with the wild-type. Fig. 5 shows the influence of the pH on the transport activity expressed as percent of the activity at pH 7.0. The pH dependence of the wild-type resembled the pH dependence of the native protein [34] , i.e., the transport activity increased with increasing the pH from pH 6.0 to pH 7.0 and, then, it decreased at more alkaline pH. The H29A mutant showed a pH dependence similar to that of the wild-type. The same pH dependence was also found for H29Y, H29F and H29Q (not shown). The H205A transport activity increased with the pH, but, surprisingly, reached a maximum at pH 8.0 instead of pH 7.0, and, then, decreased.
Discussion
In this paper the structure/function relationships of the two native His residues of the rat CAC have been investigated by site-directed mutagenesis. According to the bioinformatic predictions, the mutation of the conserved His-29, not of His-205, severely impaired the transport function, except in the case of the H29Q mutant, whose view; B) . The transmembrane α-helices are coloured as followed: H1, red (partly transparent in A); H2, light brown (partly transparent in A); H3, green; H4, emerald-green; H5, cyan; H6, blue. White or light blue (E132) surfaces highlight the residues of the salt bridge network, D32, K35, E132, K135, D231 and K234, which are numbered in black. H29 and H205 (purple), R275 and F284 (blue), D179 (red) are highlighted by stick representation and numbered with the same colour of the residues. The substrate carnitine is depicted in a ball and stick representation in red with the oxygen atoms in light brown and it is visualized in two hypothetical sites, U (upper) and L (lower). The homology structural model has been represented using the molecular visualization program VMD. activity, was comparable to that of the wild-type. This finding indicated that the main structure/function relationship of His-29 is the formation of an H-bond, most likely with the substrate. It is well known that the N amide of Gln structurally corresponds to the τ-N (distal), whereas the N amide of Asn corresponds to the π-N (vicinal) of the His imidazole [28] ; thus, only the distal N of His-29 is involved in the H-bonding. To predict which functional group of the substrate interacts with His-29, we have viewed the interactions between substrate and active site in carnitine acyl-transferases, whose structures have been resolved with X-ray crystallography [35] [36] [37] . In these enzymes, a conserved His residue (His-343 in CAT) interacts via an H-bond between the distal N of the His and the β-OH of carnitine or with the β-O-of acylcarnitines. In addition, besides other residues, a conserved Arg (Arg-518 in CAT) interacts with the carboxyl group of carnitine; the distance between the conserved His and Arg residues in the enzymes is about 10 Å (from 8.9 to 10.5 Å, calculated from the deposited PDB structures [35] [36] [37] between the distal N of His and the guanidino N groups of Arg, using the computer application Swiss PDB viewer [25] ). The transfer reaction is allowed in the enzymes by a vicinal Ser residue. In the structural model of CAC, His-29 lies at a distance of 9.8 Å from a conserved Arg (Arg-275 in rat, see Figs.1 and 6) which is located in the central cavity too. No Ser residues in the vicinity of His-29 are present in the CAC in line with absence of transferase activity. Interestingly, Arg-275 is important for function in the human CAC [26] . Thus, in analogy with the CAT enzymes, His-29 will interact via an H-bond with the alcoholic β-OH of carnitine or with the esterified β-O-of acylcarnitines, playing a role in the positioning of the substrate preceding or concomitant with the translocation towards the opposite side of the membrane. However, the binding site of carnitine would be deeper in the central cavity of the protein (Fig. 6 , L site) respect to the predicted position of the binding sites of yeast mitochondrial carriers previously proposed ( [38] and see Fig. 6 , U site). This discrepancy may be interpreted according to an alternate interaction of the substrate with an upper and a lower binding site. Even though this is a speculative hypothesis, it is in agreement with the two binding site model proposed for the yeast CTP [31] . On the basis either of this model and of the bioinformatic predictions [38] [39] [40] , in the upper binding site, carnitine should interact with Arg-275 and Asp-179 (homologues of the yeast CAC Arg-303 and Asp-204 [38] ); in the lower binding site, carnitine will interact with Arg-275 and His-29. In this site, the positioning of γ-trimethylammonium close to charged residue of the second repeat, Glu-132 (Fig. 6) , will induce the opening of the channel by perturbation of the salt bridge network, according to the translocation mechanism of carriers previously proposed [39] . The decrease of affinity for carnitine and the reduction of Vmax, which cause the reduction of transport function in H29A, H29F and H29Y mutants, and the variation of selectivity towards acylcarnitines can be explained by anomalous fluctuations of the substrate(s) which is weakly anchored to the amino acid residue-29 (see Results section). Whereas, the more evident kinetic and selectivity variations observed in H29N may be due to the formation of a strong but wrongly placed H-bond between Asn-29 and the substrate which forces it in a distorted conformation and impairs the interaction of the γ-trimethylammonium with Glu-132. The loss of transport function of the H29K and H29D mutants may be due to the formation of electrostatic interactions between the positively or negatively charged residue, introduced in the place of His-29, with the vicinal Asp-32 or Lys-135 (see Fig. 6 ). This anomalous electrostatic interaction will interfere with the network of salt bridges of the CAC.
A role in positioning of the substrate prior to the reaction, similar under some aspects to that of His-29, was previously proposed for the invariant His-1069 of the copper-transporting ATPase [17] . Among the mitochondrial carriers with known function, a conserved His is present in the corresponding position of His-29, i.e., immediately before the first repeated motif, in DIC [41] , FLX1 [42] , GTP/GDP [43] , oxodicarboxylate [44] and folate [45] carriers. No data on mutations of these specific His residues in mitochondrial carriers have been reported so far with the exception of the conserved His-41 of the folate transporter whose mutation in Ala led to some impairment of function. However, no specific role was proposed for that residue [46] .
His-205 has not a major role in the function of the CAC as demonstrated by the lack of effect on the transport activity following its substitution. However, it was found that the substitution of His-205 altered the pH dependence of the transporter, shifting the optimal activity towards more alkaline pH (Fig. 5) . Since it is known that His and Phe residues can interact in proteins leading to a stabilization of vicinal helical structures [28, 29] , the shift may be explained by the loss of an interaction between His-205 and a Phe located on a vicinal α-helix. Indeed, Phe-284 is located on the H6 and lies at a predicted distance of 3.7 Å from His-205 in the c-state of the protein (Fig. 6 ). In the wild-type the interaction His-205/Phe-284 will reduce the reciprocal fluctuation of H5 and H6, which may be associated with the conversion of the protein from the c-state to the m-state [7, 13] . This interaction, which is stronger at alkaline pH, at which the imidazole (pKa, 6.5) is deprotonated, should contribute to the decrease of activity observed in the wild-type at alkaline pH. The substitution of His-205 abolishes the interaction His-205/Phe-284 leading to the shift of the pH optimum. The hypothesized aromatic His-205/Phe-284 interaction should be a specific feature of the rat protein. In fact, the carnitine transporters of other species (Fig. 1 ) have neither His nor other aromatic residues on H5 in the vicinity of Phe-284.
